CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


29-November-2011
Cerilliant introduces a certified solution standard of the nonbenzodiazepine internal standard Zolpidem-D7.

Zolpidem-D7, 100 µg/mL Z-008
100 ug/mL in Methanol

Zolpidem, marketed as Ambien or Stilnox, is a nonbenzodiazepine used for the short-term treatment of insomnia. This stable-labeled internal standard is uniquely suited for GC/MS applications, because unlike the dimethyl-D6 analog, the deuterium label is retained in the major product ion fragment. As with dimethyl-D6 internal standard (Z-001), the D7-labeled analog is suitable for LC/MS methods.

Coming soon, Cerilliant will offer a certified solution standard of Zolpidem Phenyl-4-carboxylic acid, the major urinary metabolite of zolpidem. This item, catalog number Z-007, is now ready for pre-order.


Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn